Prazosin.txt CLINICAL USE Alpha-adrenoceptor blocker:Hypertension Congestive heart failure Raynaud’s syndrome Benign prostatic hyperplasia (BPH) DOSE IN NORMAL RENAL FUNCTION 0.5–20 mg daily in 2–3 divided doses Raynaud’s syndrome, BPH: 0.5–2 mg twice daily PHARMACOKINETICS Molecular weight                           :419.9 %Protein binding                           :97 %Excreted unchanged in urine     : <10           : Volume of distribution (L/kg)       :1.2–1.5 half-life – normal/ESRD (hrs)      :2–4/Unchanged DOSE IN RENAL IMPAIRMENT GFR (mL/MIN) 20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES CAPD                :Not dialysed. Dose as in normal renal function HD                     :Not dialysed. Dose as in normal renal functionHDF/high flux   :Unknown dialysability. Dose as in normal renal functionCAV/VVHD      :Not dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS Potentially hazardous interactions with other drugs Anaesthetics: enhanced hypotensive effect Antidepressants: enhanced hypotensive effect with MAOIs Beta-blockers: enhanced hypotensive effect, increased risk of first dose hypotensive effect Calcium-channel blockers: enhanced hypotensive effect, increased risk of first dose hypotensive effect Diuretics: enhanced hypotensive effect, increased risk of first dose hypotensive effect Moxisylyte: possibly severe postural hypotension when used in combination Vardenafil, sildenafil and tadalafil: enhanced hypotensive effect – avoid concomitant use ADMINISTRATION Reconstition– Route Oral Rate of Administration –Comments– Tags: post-by-auto-php Continue Reading Previous Previous post: PTOSIS.txtNext Next post: Pyrimethamine.txt Related News sotalol hydrochloride.txt tazocin.txt